Renal Cell Carcinoma: Symptoms, Causes and Treatment

Renal cell carcinoma is the most common type of kidney cancer in adults and is often found incidentally during imaging for another reason. With timely evaluation, treatment can be tailored to the tumor stage, kidney function, and the person’s overall health.

Overview

Renal cell carcinoma, often called RCC, is the most common kidney cancer in adults. It begins in the cells lining the tiny tubules that help filter blood and make urine. Because the kidneys sit deep in the body, this cancer can grow quietly for a while before it is noticed.

For many people, the first clue is not a symptom but an imaging study done for another reason, such as an ultrasound or CT scan for abdominal pain. That can make the diagnosis feel unexpected, especially for international patients who may be arranging care while living far from the hospital where the tumor was found. In that situation, it helps to think in stages: confirm the diagnosis, learn how far the cancer has spread, and match treatment to the person rather than the scan alone.

Renal cell carcinoma is not one single disease. There are different subtypes, and they can behave differently under the microscope and in the body. A specialist team uses pathology, imaging, and the patient’s general health to decide whether the tumor is best treated with surgery, medication, or close observation.

Symptoms

Early renal cell carcinoma may cause no symptoms at all. When symptoms do appear, they can be subtle at first and are sometimes mistaken for common urinary or back problems. That is one reason kidney imaging findings deserve careful follow-up rather than reassurance alone.

Possible symptoms include:

• Blood in the urine, which may be visible or only found on testing
• Pain or a dull ache in the side or lower back
• A lump or fullness in the abdomen or flank
• Fatigue, reduced appetite, or unexplained weight loss
• Fever that does not have a clear cause
• Swelling in the legs in some cases

Some symptoms can also arise if the cancer affects hormones or nearby structures. However, these signs do not automatically mean kidney cancer; they can occur with infections, stones, cysts, or other conditions. The key point is that persistent or unexplained changes merit medical evaluation, especially when there is blood in the urine.

Causes & Risk Factors

The exact cause of renal cell carcinoma is not always known. Like many cancers, it develops when changes in kidney cells allow them to grow and divide in an uncontrolled way. Over time, those altered cells can form a tumor.

Certain factors are associated with a higher risk of RCC. These include smoking, obesity, high blood pressure, long-term kidney disease, and some inherited syndromes that affect cancer risk. Exposure to certain chemicals and a family history of kidney cancer may also matter, though most cases are not directly inherited.

Age and sex can play a role as well, with RCC being more common in older adults and in men. Even so, risk factors do not determine the outcome for any one person. Many people with risk factors never develop kidney cancer, and some people diagnosed with RCC have none of the usual risks. That is why clinicians look at the full picture rather than a single label.

Diagnosis

Diagnosis usually begins with a conversation about symptoms, medical history, and prior imaging. If a kidney mass is seen, the next step is often high-quality imaging to learn its size, location, and whether it appears confined to the kidney or involves nearby structures. CT and MRI are commonly used because they provide detailed information that helps with treatment planning.

Blood and urine tests are often part of the workup. These tests do not diagnose RCC on their own, but they can show how well the kidneys are functioning and whether there are signs of blood loss, infection, or other changes that matter before treatment. In some cases, a biopsy is recommended to confirm the type of tumor, particularly when the result will influence whether surgery, surveillance, or another approach is best.

Staging is an important part of diagnosis because it describes how far the cancer has spread. This may involve imaging of the chest or other areas, depending on the situation. For patients arranging care from another country, it is helpful to bring copies of all scans, reports, and pathology slides if available; these can prevent delays and reduce the need to repeat tests.

Treatment Options

Treatment for renal cell carcinoma depends on the tumor’s stage, growth pattern, subtype, and the person’s overall health and kidney function. A small kidney mass may be treated very differently from a cancer that has spread beyond the kidney. This is where a multidisciplinary team becomes especially valuable, because surgery, oncology, radiology, and pathology all shape the plan.

Surgery is often the main treatment for localized RCC. Depending on the case, the surgeon may remove the entire kidney or only the tumor with a margin of healthy tissue. Preserving kidney function is an important goal whenever possible. For some smaller tumors or for patients who are not good candidates for surgery, active surveillance or minimally invasive techniques such as ablation may be considered.

When the cancer has spread or is at higher risk of returning, medication-based treatment may be recommended. These options can include targeted therapies and immunotherapy, chosen according to the tumor’s behavior and the patient’s condition. Radiation is not usually the primary treatment for RCC, but it may be used in selected situations to relieve symptoms or control disease in specific sites.

Recovery planning matters just as much as the procedure itself. Patients traveling for treatment should ask how long they are likely to stay, when pathology results will be reviewed, what follow-up imaging is needed, and whether any medication changes should be made before flying home. Clear instructions make the transition safer and less stressful.

Prevention & Self-care

There is no guaranteed way to prevent renal cell carcinoma, but healthy habits can reduce some of the risks linked to kidney cancer and support overall kidney health. Quitting smoking is one of the most meaningful steps a person can take. Managing blood pressure, maintaining a healthy weight, and staying physically active are also helpful.

People with chronic kidney disease or a family history of kidney cancer may benefit from regular medical follow-up. If a kidney mass has already been identified, self-care becomes more about preparation and recovery than prevention. That includes keeping a symptom diary, bringing a complete medication list to appointments, and asking the care team about hydration, pain control, and activity limits after treatment.

For international patients, practical self-care also includes organizing records before travel, confirming which test results are needed at the destination hospital, and arranging a local physician for follow-up once home. A smooth handoff reduces the chance of missed appointments or confusion about surveillance imaging.

When to See a Doctor

Medical evaluation is important if there is blood in the urine, persistent pain in the flank or back, an unexplained abdominal mass, or weight loss that does not have another clear cause. A person should also seek care if an imaging test shows a kidney mass, even when they feel well. Early review can clarify whether the finding is harmless, needs monitoring, or requires treatment.

Urgent assessment is appropriate if urinary bleeding is heavy, severe pain develops, or symptoms such as fainting, shortness of breath, or marked weakness appear. These situations may not be caused by cancer itself, but they still deserve prompt attention. The goal is not to panic; it is to avoid delaying care when the body is signaling that something has changed.

For patients who are considering treatment abroad, an experienced team can help interpret previous scans, confirm the diagnosis, and coordinate surgery or oncology care with a realistic follow-up plan. Acibadem Health Point’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat renal cell carcinoma for international patients, with attention to continuity of care after discharge.

Living With the Diagnosis

A diagnosis of renal cell carcinoma often raises practical questions immediately: How much kidney will be left? Will there be treatment after surgery? What does follow-up look like if care is split between countries? These are normal questions, and they deserve clear answers from the treating team.

Many patients do well when the disease is found early and treatment is organized carefully. Even when RCC is more advanced, modern therapies can help control disease and preserve quality of life. Regular surveillance matters because kidney cancer follow-up is usually a long-term process, with imaging and clinic visits scheduled over time.

It also helps to keep expectations realistic. Recovery may involve fatigue, temporary dietary changes, or a gradual return to activity. Questions about work, travel, exercise, and medication can be discussed before leaving the hospital so that the patient is not trying to solve them alone later.

Frequently asked questions

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.